Kaleido Biosciences Inc. (KLDO) PT Lowered to $11 at Chardan Capital Markets

November 12, 2021 7:25 AM EST Send to a Friend
Chardan Capital Markets analyst Keay Nakae lowered the price target on Kaleido ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login